Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

NCT02294253 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: Buprenorphine/naloxone

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]